Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM28257 Fibroblast from Skin, Skin

Description:

COCKAYNE SYNDROME, TYPE A; CSA
EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8

Affected:

Yes

Sex:

Male

Age:

1 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Biopsy Source Skin
Cell Type Fibroblast
Tissue Type Skin
Transformant Untransformed
Sample Source Fibroblast from Skin, Skin
Race White
Ethnicity Not Hispanic/Latino
Country of Origin USA
Family History N
Relation to Proband proband
Confirmation Molecular characterization before cell line submission to CCR
Species Homo sapiens
Common Name Human
Remarks See "Phenotypic Data" tab. Clinically affected. No history of birth defects, genetic disorders or developmental delay.

Characterizations

back to top
PDL at Freeze 5.14
Passage Frozen 2
 
Gene ERCC8
Chromosomal Location 5q12.1
Allelic Variant 1 609412.0003; COCKAYNE SYNDROME
Identified Mutation c.37G>T (p.GLU13*)
 
Gene ERCC8
Chromosomal Location 5q12.1
Allelic Variant 2 ; COCKAYNE SYNDROME
Identified Mutation C.173+1G>A (SPLICE DONOR)

Phenotypic Data

back to top
Demographic Data
Relation to Proband proband
Age at Sampling 1 YR
Sex Male
Age at Diagnosis(If not a control) 15 MO
Hispanic or Latino/Not Hispanic or Latino Not Hispanic/Latino
Racial Category White
Country USA
 
Data Elements
Clinical Element Type: General NIGMS Catalog Remarks
  (Baseline)
Mutation Information
Gene, variant, consequence, and exon number:  AUTOSOMAL RECESSIVE COCKAYNE SYNDROME (CS TYPE II); TRIO WHOLE EXOME SEQUENCING (WES) OF BUCCAL SWAB DNA REVEALED TWO PATHOGENIC HETEROZYGOUS VARIANTS IN TRANS IN THE ERCC8 GENE: PATERNALLY INHERITED C.37G>T (P.GLU13*), AND MATERNALLY INHERITED C.173+1G>A (SPLICE DONOR)
Zygosity:  Compound Heterozygous
Notes: VARIANTS ARE IN TRANS
Other variants:  CARRIER OF THE DUARTE2 VARIANT IN THE GALT GENE - NOT CAUSAL FOR SYMPTOMS
Age of Symptom Onset and Age at Diagnosis
Age of Symptom Onset:  BIRTH
In Utero History Information
Additional Information:  MOTHER WITH GESTATIONAL DIABETES AND HYPERTENSION
Birth History Information
Low birth weight
Jaundice
Failure to thrive
Additional Information:  37 WEEKS GESTATION; LABOR INDUCED DUE TO SMALL SIZE, MATERNAL ELEVATED BLOOD PRESSURE, AND CONCERNING FETAL HEART RATE AND BREATHING; NO FETAL COMPLICATIONS DURING DELIVERY; 5LB 6OZ AT BIRTH; BORN TO G1P0 MOTHER WITH A SINUS INFECTION AND FEVER TREATED BY ANTIBIOTICS; BORDERLINE BLOOD SUGAR LEVELS AND JAUNDICE (TREATED BY PHOTOTHERAPY); EYES ROLLED DOWNWARDS AT BIRTH; MODERATE POSTNATAL GROWTH RETARDATION; POOR WEIGHT GAIN AS INFANT; GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Dysmorphic Features
Microcephaly
Additional Information:  EYES SLANT DOWN (MINIMAL)
Neurological Symptoms
Hypotonia
Additional Information:  AREFLEXIA
Optical and Audiological Symptoms
Defective vision
Nystagmus
Additional Information:  ABNORMALITY OF THE EYE, JUVENILE CATARACT (BOTH EYES), POSTERIOR LENTICONUS, ABNORMAL EYE MORPHOLOGY AND PHYSIOLOGY; AT 2 MONTHS HAD BLOCKED TEAR DUCT AND HAD ISSUES TRACKING AND FOCUSING; AT 3 MONTHS THERE WAS NO RED REFLEX BILATERALLY AND HE HAD 4+ CATARACTS IN RIGHT LENS AND 3+ CATARACTS IN LEFT LENS
Musculoskeletal Symptoms
Additional Information:  MUSCULAR HYPOTONIA; DECREASED MUSCLE MASS
Developmental Milestones
Delayed speech and language development
Global developmental delay
Delayed fine motor skills
Delayed gross motor skills
Abnormal height for age
Abnormal weight for age
Sitting Without Assistance:  Achieved and maintained
Additional Information:  GROWTH ABNORMALITY; MILD MOTOR DELAY; EXPRESSIVE LANGUAGE DELAY; SPEECH DIFFICULTY; UNDERSTANDS SPEECH; DOES NOT TALK; VERY GOOD UNDERSTANDING AND IS "SMART" - RESPONDS TO SUGGESTIONS AND COMMANDS
Gastrointestinal Symptoms
Eating difficulties
Genitourinary Symptoms
Respiratory and Cardiovascular Symptoms
Cognitive and Behavioral Symptoms
Additional Information:  VERY SOCIAL, HAS A SOCIAL SMILE AND LAUGHS
Additional Information
Uncategorized Symptoms:  ALLERGIC TO FLAGYL (METRONIDAZOLE)
Testing Performed
Optical and Audiological Testing:  AT 12 MONTHS OF AGE, WAS TRACKING; HAD LESS NYSTAGMUS; AT 15 MONTHS, WAS SITTING INDEPENDENTLY
Musculoskeletal and Developmental Testing:  WEIGHT: <1%ILE; HEIGHT: 2%ILE; HEAD CIRCUMFERENCE: <1%ILE; BMI: 13.8; AT 12 MONTHS, HAD IMPROVED HEAD CONTROL
Metabolic, Hematologic, and Endocrinologic Testing:  ELEVATED HEPATIC TRANSAMINASE, LACTIC ACIDOSIS, HYPERALANINEMIA; ABNORMALITY OF CIRCULATING ENZYME LEVEL, ABNORMAL ENZYME/COENZYME ACTIVITY
Treatments and Assistive Devices
Occupational therapy
Physical therapy
Speech therapy
Additional Testing:  VISION THERAPY; WEARS CONTACTS; EXTRACAPSULAR SURGERY OF CATARACTS
Medications
 CYCLOPENTOLATE HCL, 1% SOLUTION: DUOCAL ORAL POWDER; VITAMIN D LIQUID; DOCUSATE SODIUM (COLACE)
Family History
 PARENTS ARE CARRIERS OF MUTATIONS IN ERCC8; NO CONSANGUINITY; FATHER HAS PATERNAL ANCESTRY FROM ITALY/GREECE AND SEPHARDIC JEWISH HERITAGE AND MATERNAL EASTERN EUROPEAN ANCESTRY WITH ASHKENAZI JEWISH HERITAGE; MOTHER IS OF ASIAN INDIAN DESCENT; MOTHER HAS HISTORY OF POLYCYSTIC OVARY SYNDROME (PCOS) AND WEARS GLASSES WITH -10 AND -10.5 PRESCRIPTION STRENGTH; AT <40 YRS, MOTHER'S SISTER HAS RETINAL PIGMENTATION ISSUES (NO IMPACT ON VISION), HYPOTHYROIDISM, ELEVATED BLOOD PRESSURE, AND ACQUIRED DEAFNESS AT 6 MONTHS FROM A BACTERIAL INFECTION; MATERNAL GRANDFATHER HAD TRIPLE BYPASS SURGERY IN HIS 60'S AND GLAUCOMA AND CATARACT SURGERY; MATERNAL GRANDFATHER'S FATHER DIED OF A SUDDEN HEART ATTACK IN HIS EARLY 60'S; PATERNAL UNCLE HAS DAUGHTER WITH AUTISM AND A DAUGHTER WHO HAD GLASSES/CORRECTIVE LENSES FOR STRABISMUS FROM A YOUNG AGE; PATERNAL UNCLE'S WIFE HAD A MISCARRIAGE; PATERNAL GRANDFATHER’S FAMILY HAS A HISTORY OF ALZHEIMER’S; PATERNAL GRANDMOTHER’S FATHER DIED OF CANCER AT 20-30 YRS
Remarks See "Phenotypic Data" tab. Clinically affected. No history of birth defects, genetic disorders or developmental delay.

External Links

back to top
Gene Cards CKN1
ERCC8
Gene Ontology GO:0003702 RNA polymerase II transcription factor activity
GO:0005515 protein binding
GO:0005634 nucleus
GO:0006281 DNA repair
GO:0006355 regulation of transcription, DNA-dependent
GO:0007605 perception of sound
NCBI Gene Gene ID:1161
NCBI GTR 216400 COCKAYNE SYNDROME A; CSA
609412 EXCISION REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8
OMIM 216400 COCKAYNE SYNDROME A; CSA
609412 EXCISION REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8
Omim Description COCKAYNE SYNDROME, TYPE A; CSA
  COCKAYNE SYNDROME, TYPE I; CKN1

Culture Protocols

back to top
Cumulative PDL at Freeze 5.14
Passage Frozen 2
Split Ratio 1:7
Temperature 37 C
Percent CO2 5%
Percent O2 3%
Medium Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube